Total Payments
$4,461
2024 Payments
$1,373
Companies
32
Transactions
279
Medicare Patients
3,410
Medicare Billing
$189,940
Payment Breakdown by Category
Food & Beverage$4,441 (99.6%)
Education$19.85 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,441 | 276 | 99.6% |
| Education | $19.85 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $702.31 | 33 | $0 (2024) |
| PFIZER INC. | $623.85 | 43 | $0 (2024) |
| ABBVIE INC. | $545.60 | 35 | $0 (2024) |
| Novo Nordisk Inc | $298.73 | 18 | $0 (2024) |
| Amgen Inc. | $249.10 | 22 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $246.60 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $226.26 | 14 | $0 (2024) |
| Abbott Laboratories | $212.89 | 11 | $0 (2024) |
| Lilly USA, LLC | $199.81 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $169.05 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,373 | 83 | AstraZeneca Pharmaceuticals LP ($201.90) |
| 2023 | $1,427 | 84 | PFIZER INC. ($281.51) |
| 2022 | $926.29 | 64 | ABBVIE INC. ($202.87) |
| 2021 | $735.33 | 48 | AstraZeneca Pharmaceuticals LP ($190.30) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Bone Health | ||||||
| 11/22/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO, ROTARIX | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: PAIN | ||||||
| 11/04/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Insomnia | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Diabetes Care | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 776 | 1,035 | $121,678 | $48,718 |
| 2022 | 14 | 879 | 1,155 | $125,586 | $48,774 |
| 2021 | 13 | 871 | 1,182 | $122,789 | $49,896 |
| 2020 | 16 | 884 | 1,119 | $117,381 | $42,553 |
Total Patients
3,410
Total Services
4,491
Medicare Billing
$189,940
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 242 | $47,432 | $14,910 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $18,422 | $8,766 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 203 | $26,593 | $8,645 | 32.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 40 | 40 | $12,520 | $5,214 | 41.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 24 | 24 | $3,528 | $3,432 | 97.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,806 | $2,367 | 84.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 141 | 197 | $1,773 | $1,655 | 93.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,749 | $942.81 | 53.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 24 | 24 | $1,656 | $913.92 | 55.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $1,782 | $780.30 | 43.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 31 | 57 | $1,683 | $542.64 | 32.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $1,359 | $494.34 | 36.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 25 | $375.00 | $55.00 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 232 | $44,947 | $14,289 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 249 | $32,211 | $10,982 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 93 | 93 | $20,181 | $9,705 | 48.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 33 | 33 | $10,210 | $4,414 | 43.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 47 | 47 | $3,280 | $3,214 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 52 | 53 | $2,803 | $1,453 | 51.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 29 | 29 | $2,001 | $1,053 | 52.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 51 | 51 | $1,851 | $742.41 | 40.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 34 | $2,634 | $731.87 | 27.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 148 | 224 | $2,016 | $663.00 | 32.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 36 | 57 | $1,764 | $546.27 | 31.0% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 14 | 14 | $784.00 | $513.15 | 65.5% |
About Robert Lancaster, ARNP
Robert Lancaster, ARNP is a Family healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1811409006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Lancaster, ARNP has received a total of $4,461 in payments from pharmaceutical and medical device companies, with $1,373 received in 2024. These payments were reported across 279 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,441).
As a Medicare-enrolled provider, Lancaster has provided services to 3,410 Medicare beneficiaries, totaling 4,491 services with total Medicare billing of $189,940. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cedar Rapids, IA
- Active Since 10/29/2017
- Last Updated 10/29/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1811409006
Products in Payments
- BREZTRI (Drug) $406.59
- UBRELVY (Drug) $277.52
- ELIQUIS (Drug) $257.35
- NURTEC ODT (Drug) $255.51
- XIFAXAN (Drug) $239.27
- FARXIGA (Drug) $226.95
- XARELTO (Drug) $169.05
- TRADJENTA (Drug) $156.06
- Rybelsus (Drug) $133.15
- QULIPTA (Drug) $132.34
- Otezla (Drug) $129.13
- FREESTYLE LIBRE 3 (Device) $128.27
- Veozah (Drug) $115.96
- VRAYLAR (Drug) $105.41
- PREVNAR 20 (Biological) $90.18
- FREESTYLE LIBRE 2 (Device) $84.62
- JARDIANCE (Drug) $74.63
- LEQVIO (Drug) $73.19
- Ozempic (Drug) $71.53
- MOUNJARO (Drug) $71.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cedar Rapids
Sara Butler, Arnp, ARNP
Family — Payments: $5,259
Family $5,259
Frankie Dunbar, Arnp, ARNP
Family — Payments: $3,077
Family $3,077
Amy Freeman, Arnp, ARNP
Family — Payments: $2,725
Family $2,725
Mrs. Hillary Behn, Arnp, ARNP
Family — Payments: $2,173
Family $2,173
Molly Garber, Arnp, ARNP
Family — Payments: $2,081
Family $2,081
Jessica Coffey, Arnp, ARNP
Family — Payments: $2,038
Family $2,038